NVCT:NASDAQ, Nuvectis Pharma, Inc.

NVCT stock overview

Nuvectis Pharma, Inc. (NVCT:NASDAQ) closed at $19.39 on November 20, 2026, down 2.27% on the day. The stock trades 33.8% below its 52-week high of $29.28 and 236.0% above its 52-week low of $5.77. Over the past year, it gained 223.7%. Nuvectis Pharma, Inc. is part of the Health Care sector.

Key figures

Price
$19.39
Day change
-2.27%
Volume
301,603
Average volume
204,734
Market cap
666M+
52-week range
$5.77 – $29.28
50-day average
$20.30
200-day average
$15.41

Price action over the past year

In 252 trading sessions since November 20, 2025, NVCT closed higher on 139 days (55%). Its best day was June 24, 2026 (+39.49%) and its worst was June 30, 2026 (-35.54%). The stock moved 10% or more in a single session 11 times.

Recent signals

NVCT news

About Nuvectis Pharma, Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its pipeline products include NXP800, NXP900.

Similar stocks

Find more stocks like NVCT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.